Diabetes, obesity & metabolism
Recommendations for real-world evidence of efficacy and safety of GLP-1 agonists in Prader-Willi syndrome: Report of a workshop held by the Foundation for Prader-Willi Research and International Prader Willi Syndrome Organisation.
Nick Finer, Theresa Strong, Caroline Vrana-Diaz, Diane E J Stafford
Published: 202610.1111/dom.70282
No abstract available for this study.